Medical Cannabis Market

Medicinal cannabis are also known as Medical marijuana, which area used either to treat disease or to improve their symptoms. The two cannabinoids - delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) are used in treatment of certain disease or health conditions such as pain, blood pressure, memory, concentration, appetite, sensory stimulus, muscular problems, and seizures.

Medical Cannabis Market contains market size and forecasts of Medical Cannabis in global, including the following market information:

Global Medical Cannabis Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Medical Cannabis Market Sales, 2017-2022, 2023-2028, (MT)

Global top five Medical Cannabis companies in 2021 (%)

The global Medical Cannabis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tetrahydrocannabinol (THC) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Medical Cannabis include BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc, Canopy Growth Corporation, Insys Therapeutics, Inc, Aphria, Inc, MGC Pharmaceuticals Limited and GW Pharmaceuticals, plc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Medical Cannabis manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Medical Cannabis Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Medical Cannabis Market Segment Percentages, by Type, 2021 (%)

• Tetrahydrocannabinol (THC)
• Cannabidiol (CBD)

Global Medical Cannabis Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Medical Cannabis Market Segment Percentages, by Application, 2021 (%)

• Pain
• Arthritis
• Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
• Others

Global Medical Cannabis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Medical Cannabis Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Medical Cannabis revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Medical Cannabis revenues share in global market, 2021 (%)
• Key companies Medical Cannabis sales in global market, 2017-2022 (Estimated), (MT)
• Key companies Medical Cannabis sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• BOL Pharma
• Tilray
• Medreleaf Corporation
• Aurora Cannabis, Inc
• Canopy Growth Corporation
• Insys Therapeutics, Inc
• Aphria, Inc
• MGC Pharmaceuticals Limited
• GW Pharmaceuticals, plc
• Medical Marijuana Inc
• Medipharm Labs